141 related articles for article (PubMed ID: 28171719)
1. Nano-Hydroxyapatite Bone Substitute Functionalized with Bone Active Molecules for Enhanced Cranial Bone Regeneration.
Teotia AK; Raina DB; Singh C; Sinha N; Isaksson H; Tägil M; Lidgren L; Kumar A
ACS Appl Mater Interfaces; 2017 Mar; 9(8):6816-6828. PubMed ID: 28171719
[TBL] [Abstract][Full Text] [Related]
2. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties.
Raina DB; Larsson D; Mrkonjic F; Isaksson H; Kumar A; Lidgren L; Tägil M
J Control Release; 2018 Feb; 272():83-96. PubMed ID: 29329716
[TBL] [Abstract][Full Text] [Related]
3. Nanohydroxyapatite Based Ceramic Carrier Promotes Bone Formation in a Femoral Neck Canal Defect in Osteoporotic Rats.
Qayoom I; Teotia AK; Kumar A
Biomacromolecules; 2020 Feb; 21(2):328-337. PubMed ID: 31637919
[TBL] [Abstract][Full Text] [Related]
4. Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery.
Raina DB; Qayoom I; Larsson D; Zheng MH; Kumar A; Isaksson H; Lidgren L; Tägil M
Biomaterials; 2019 Jan; 188():38-49. PubMed ID: 30321863
[TBL] [Abstract][Full Text] [Related]
5.
Horstmann PF; Raina DB; Isaksson H; Hettwer W; Lidgren L; Petersen MM; Tägil M
Tissue Eng Part A; 2017 Dec; 23(23-24):1403-1412. PubMed ID: 28537526
[TBL] [Abstract][Full Text] [Related]
6. Biocomposite macroporous cryogels as potential carrier scaffolds for bone active agents augmenting bone regeneration.
Raina DB; Isaksson H; Teotia AK; Lidgren L; Tägil M; Kumar A
J Control Release; 2016 Aug; 235():365-378. PubMed ID: 27252151
[TBL] [Abstract][Full Text] [Related]
7. Repair of rat cranial bone defects with nHAC/PLLA and BMP-2-related peptide or rhBMP-2.
Li J; Hong J; Zheng Q; Guo X; Lan S; Cui F; Pan H; Zou Z; Chen C
J Orthop Res; 2011 Nov; 29(11):1745-52. PubMed ID: 21500252
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of recombinant human bone morphogenetic protein-2 and -9 on bone formation in rat calvarial critical-size defects.
Nakamura T; Shirakata Y; Shinohara Y; Miron RJ; Hasegawa-Nakamura K; Fujioka-Kobayashi M; Noguchi K
Clin Oral Investig; 2017 Dec; 21(9):2671-2679. PubMed ID: 28197731
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of rhBMP-2 and zoledronic acid using calcium sulfate/hydroxyapatite carrier as a bioactive bone substitute to enhance and accelerate spinal fusion.
Tian X; Vater C; Raina DB; Findeisen L; Matuszewski LM; Tägil M; Lidgren L; Winkler A; Gottwald R; Modler N; Schaser KD; Disch AC; Zwingenberger S
Bioact Mater; 2024 Jun; 36():256-271. PubMed ID: 38487704
[TBL] [Abstract][Full Text] [Related]
10. Long-term controlled delivery of rhBMP-2 from collagen-hydroxyapatite scaffolds for superior bone tissue regeneration.
Quinlan E; Thompson EM; Matsiko A; O'Brien FJ; López-Noriega A
J Control Release; 2015 Jun; 207():112-9. PubMed ID: 25817394
[TBL] [Abstract][Full Text] [Related]
11. Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model.
Kodera R; Miyazaki M; Yoshiiwa T; Kawano M; Kaku N; Tsumura H
Bone; 2014 Jan; 58():26-32. PubMed ID: 24103577
[TBL] [Abstract][Full Text] [Related]
12. New nano-hydroxyapatite in bone defect regeneration: A histological study in rats.
Kubasiewicz-Ross P; Hadzik J; Seeliger J; Kozak K; Jurczyszyn K; Gerber H; Dominiak M; Kunert-Keil C
Ann Anat; 2017 Sep; 213():83-90. PubMed ID: 28655570
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of xenogeneic and synthetic bone-block substitute materials with/without recombinant human bone morphogenetic protein-2: A preclinical study using a rabbit calvarium model.
Lim HC; Paeng KW; Jung UW; Benic GI
J Clin Periodontol; 2021 Aug; 48(8):1126-1136. PubMed ID: 34109662
[TBL] [Abstract][Full Text] [Related]
14. Bone augmentation using a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute materials with and without recombinant human bone morphogenetic protein-2.
Thoma DS; Kruse A; Ghayor C; Jung RE; Weber FE
Clin Oral Implants Res; 2015 May; 26(5):592-8. PubMed ID: 25138542
[TBL] [Abstract][Full Text] [Related]
15. Biomodulation of an implant for enhanced bone-implant anchorage.
Raina DB; Larsson D; Sezgin EA; Isaksson H; Tägil M; Lidgren L
Acta Biomater; 2019 Sep; 96():619-630. PubMed ID: 31301423
[TBL] [Abstract][Full Text] [Related]
16. Repair of rat calvarial bone defects by controlled release of rhBMP-2 from an injectable bone regeneration composite.
Tan R; She Z; Wang M; Yu X; Jin H; Feng Q
J Tissue Eng Regen Med; 2012 Aug; 6(8):614-21. PubMed ID: 21916016
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of zoledronate on early-stage osteoinduction by recombinant human bone morphogenetic protein 2 in an osteoporosis model.
Lee JH; Baek HR; Lee KM; Zheng GB; Shin SJ; Jin YZ
Growth Factors; 2015; 33(3):220-8. PubMed ID: 26099999
[TBL] [Abstract][Full Text] [Related]
18. New scaffold for recombinant human bone morphogenetic protein-2.
Kamakura S; Nakajo S; Suzuki O; Sasano Y
J Biomed Mater Res A; 2004 Nov; 71(2):299-307. PubMed ID: 15368218
[TBL] [Abstract][Full Text] [Related]
19. A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone.
Raina DB; Isaksson H; Hettwer W; Kumar A; Lidgren L; Tägil M
Sci Rep; 2016 May; 6():26033. PubMed ID: 27189411
[TBL] [Abstract][Full Text] [Related]
20. A novel nano-hydroxyapatite/synthetic polymer/bone morphogenetic protein-2 composite for efficient bone regeneration.
Bal Z; Korkusuz F; Ishiguro H; Okada R; Kushioka J; Chijimatsu R; Kodama J; Tateiwa D; Ukon Y; Nakagawa S; Dede EÇ; Gizer M; Korkusuz P; Yoshikawa H; Kaito T
Spine J; 2021 May; 21(5):865-873. PubMed ID: 33493682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
